ImmunoGen (United States)
How to Contact Immunogen
Phone
1-781-895-0600About ImmunoGen
ImmunoGen, now part of AbbVie, pioneered antibody-drug conjugate (ADC) technology for cancer treatment. The company developed Elahere (mirvetuximab soravtansine), an ADC targeting folate receptor alpha for platinum-resistant ovarian cancer. ImmunoGen’s ADC platform enables targeted delivery of cytotoxic agents to cancer cells while minimizing damage to healthy tissue.
Medications
Medications Manufactured by Immunogen
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
Report to
👉
(UK)
👉
(US)
